Fermenta Biotech Limited (BOM:506414)

India flag India · Delayed Price · Currency is INR
300.35
+1.45 (0.49%)
At close: Oct 10, 2025
0.49%
Market Cap8.84B
Revenue (ttm)5.28B
Net Income (ttm)1.05B
Shares Out29.43M
EPS (ttm)35.74
PE Ratio8.40
Forward PEn/a
Dividend2.50 (0.83%)
Ex-Dividend DateAug 6, 2025
Volume11,209
Average Volume33,255
Open304.90
Previous Close298.90
Day's Range295.50 - 305.00
52-Week Range219.00 - 449.00
Beta-0.16
RSI35.10
Earnings DateNov 14, 2025

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup... [Read more]

Industry Pharmaceutical Preparations
Founded 1951
Employees 606
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506414
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.